T1	Participants 298 353	610 patients undergoing coronary artery bypass grafting
T2	Participants 462 536	All patients received antithrombotic treatment, either aspirin or warfarin
T3	Participants 538 606	Their diet and serum phospholipid fatty acid profiles were monitored
